Itay Friedman

Itay serves as Biond’s VP Clinical Development since 2018. He has over 15 years of diversified R&D and Commercial experience developing and delivering innovative medicines and medical technologies. Itay joined Biond from Bristol-Myer Squibb (BMS) where he was Medical Affairs lead for Oncology, Hemato-oncology, and Virology brands in addition to holding regional Business Development and global commercial roles. Prior to BMS he served as Director of Clinical Services and Product Owner at Perigen, a digital healthcare company developing innovative perinatal software solutions. Itay received a B.Sc. with honors, and earned his M.D. from the Faculty of Medicine, Hebrew University, Israel.